The complicated news on device recalls
There were only 167 device recalls in the third quarter, which is down 39 percent from the previous quarter and the lowest it’s been since the fourth quarter of 2011.
Anthem to create its own PBM, IngenioRx, with CVS Health
Anthem has signed a five-year contract with CVS Health to establish the pharmacy benefit management company, which will begin offering services in 2020.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Roche doubles down on diabetes, even with reimbursement cuts
While the likes of Johnson & Johnson bow out of the diabetes business, Roche, on the other hand, is leveraging digital tools to lower costs, while attempting to reach the largest volume of patients.
mySugr CEO talks about Roche acquisition and what’s to come with digital health-pharma deals (Q&A)
mySugr cofounder and CEO Frank Westermann responds to questions about the recent acquisition of his smartphone-enabled diabetes management business and what will come next.
Analysts: Zimmer Biomet CEO’s departure long-needed
Zimmer Biomet pre-announced disappointing second-quarter results while also revealing that David Dvorak had stepped down as CEO, a move that some analysts feel was long needed.
Anthem to pay record $115 million to settle data breach lawsuit
That 2015 Anthem data breach wasn't so easily forgotten. The health insurer has agreed to pay $115 million to settle a class-action lawsuit over the breach, which impacted 78.8 million individuals.
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Reimagining primary care is “harder than rocket science”
Primary care isn't so easy after all. Geared toward Medicare-eligible adults, Chicago-based Oak Street Health has a new way of rethinking healthcare and making primary care doctors heroes.
Not sold: FDA demands more data on Eli Lilly’s rheumatoid arthritis drug
Keep the champagne on ice. In an unexpected twist, the FDA has requested more dosage and safety data for Eli Lilly's baricitinib (Olumiant) — a delay that could cost millions.
Teacher’s pet Eli Lilly announces $850M investment in U.S.
Eli Lilly has publicized plans to invest $850 million in the United States throughout 2017, expanding operations in Indiana and doubling-down on diabetes manufacturing. Just what the president wants to hear.
The biggest takeaway from the annual meeting of orthopedic surgeons (AAOS)
The shift from volume to value is no where more apparent than in the orthopedics specialty where vendors that once obsessed over titanium and steel are now focusing on services to manage the bundled payment era.
Maximize Revenue and Patient Care with Strategic Weight Loss Management
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
The robotic have-not: How J&J plans to woo hospitals, knee surgeons
As the buzz around robotics grows, J&J 's DePuy Synthes is touting the clinical and economic evidence tied to its non-robotic knee platform to help hospitals navigate the bundled payments era, but will that sway them?
From real estate to healthcare: Trulia cofounder’s new health IT venture takes on Type 2 diabetes (Updated)
Virta Health's approach is designed to help patients lower their hemoglobin A1c levels and reduce or eliminate prescription medications. The goal is to reverse the effects of Type 2 diabetes, and cure it.
With the Healthy Indiana Plan up for renewal, is the Medicaid expansion experiment working?
The program's renewal is significant because the initial application and expansion happened on the watch of then-governor and now Vice President Mike Pence. And Seema Verma, who is President Donald Trump’s pick to lead the Centers for Medicare & Medicaid Services, helped design it.
Lilly social media guru Jerry Matczak, who actually listened to patients, dies
Gerald "Jerry" Matczak of Eli Lilly & Co. was a rare breed in the pharmaceutical world, someone who not only embraced social media, but also listened to activist patients.
Trinity Health at Home goes big with Vivify remote monitoring
The goal of the remote home health program is to reduce visits to the emergency room as well as inpatient admissions for high-risk patients.